BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.16B |
| 2 |
AbbVie
ABBV
|
+$1.93B |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$1.81B |
| 4 |
Otis Worldwide
OTIS
|
+$1.67B |
| 5 |
Carrier Global
CARR
|
+$1.43B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$3.74B |
| 2 |
RTN
Raytheon Company
RTN
|
+$2.93B |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$1.67B |
| 4 |
CY
Cypress Semiconductor
CY
|
+$779M |
| 5 |
iShares MBS ETF
MBB
|
+$772M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.92% |
| 2 | Healthcare | 14.84% |
| 3 | Financials | 12.13% |
| 4 | Consumer Discretionary | 10.93% |
| 5 | Communication Services | 8.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LJPC
3401
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $6.36M | ﹤0.01% |
1,493,434
-57,920
| -4% | -$353K |
|
3402
Altisource Portfolio Solutions
ASPS
$62.9M
| $6.33M | ﹤0.01% |
53,665
-11,452
| -18% | -$941K |
|
|
FFNW
3403
DELISTED
First Financial Northwest, Inc
FFNW
| $6.31M | ﹤0.01% |
651,293
-279,508
| -30% | -$2.59M |
|
3404
Mid Penn Bancorp
MPB
$959M
| $6.31M | ﹤0.01% |
342,273
-16,648
| -5% | -$313K |
|
|
EEX
3405
DELISTED
Emerald Holding
EEX
| $6.26M | ﹤0.01% |
2,033,579
+82,338
| +4% | +$195K |
|
3406
Victory Capital Holdings
VCTR
$6.99B
| $6.26M | ﹤0.01% |
364,227
+6,298
| +2% | +$98.8K |
|
3407
Barnes & Noble Education
BNED
$434M
| $6.25M | ﹤0.01% |
39,062
-24,089
| -38% | -$3.91M |
|
|
HFRO
3408
Highland Opportunities and Income Fund
HFRO
$402M
| $6.25M | ﹤0.01% |
775,934
-949,066
| -55% | -$7.79M |
|
3409
Altimmune
ALT
$583M
| $6.22M | ﹤0.01% |
581,280
+545,063
| +1,505% | +$2.99M |
|
3410
Lifetime Brands
LCUT
$221M
| $6.18M | ﹤0.01% |
919,395
+38,058
| +4% | +$204K |
|
3411
NACCO Industries
NC
$306M
| $6.18M | ﹤0.01% |
265,107
-27,045
| -9% | -$729K |
|
3412
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.9B
| $6.17M | ﹤0.01% |
63,888
+6,232
| +11% | +$557K |
|
3413
Gencor Industries
GENC
$254M
| $6.16M | ﹤0.01% |
487,296
-34,331
| -7% | -$397K |
|
3414
EVI Industries
EVI
$186M
| $6.12M | ﹤0.01% |
281,897
+17,044
| +6% | +$336K |
|
3415
Mustang Bio
MBIO
$4.6M
| $6.1M | ﹤0.01% |
2,557
-30
| -1% | -$70.1K |
|
|
EVBN
3416
DELISTED
Evans Bancorp Inc
EVBN
| $6.08M | ﹤0.01% |
261,251
+11,382
| +5% | +$279K |
|
|
MRLN
3417
DELISTED
Marlin Business Services Corp
MRLN
| $6.05M | ﹤0.01% |
715,591
+58,738
| +9% | +$455K |
|
|
GBL
3418
DELISTED
GAMCO Investors, Inc.
GBL
| $6.05M | ﹤0.01% |
454,503
-20,208
| -4% | -$252K |
|
3419
Intellicheck
IDN
$76.3M
| $6.02M | ﹤0.01% |
797,577
+750,110
| +1,580% | +$4.55M |
|
|
SCTL
3420
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $6.01M | ﹤0.01% |
1,321,593
-19,432
| -1% | -$120K |
|
3421
PUT
AerCap
AER
$23.5B
| $6.01M | ﹤0.01% |
+195,000
| New | +$5.57M |
|
3422
Red Violet
RDVT
$1.14B
| $6M | ﹤0.01% |
340,376
+305,855
| +886% | +$5.72M |
|
|
FM
3423
DELISTED
iShares Frontier and Select EM ETF
FM
| $5.99M | ﹤0.01% |
247,592
+6,349
| +3% | +$145K |
|
3424
AdaptHealth
AHCO
$752M
| $5.95M | ﹤0.01% |
369,716
+363,262
| +5,628% | +$6.07M |
|
3425
Hawthorn Bancshares
HWBK
$274M
| $5.95M | ﹤0.01% |
339,683
-3,819
| -1% | -$60.2K |
|
Similar funds
BlackRock's Q2 2020 Portfolio in Review
As of Q2 2020, BlackRock held 5,263 positions worth $2.51T, up 23% from $2.04T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q2 2020 filing shows 247 new, 2,443 increased, 1,910 reduced and 215 closed positions. Its largest new stake was Otis Worldwide: 32,136,910 shares worth $1.83B. The largest sale was Allergan plc, an estimated $3.74B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2020 buy was Otis Worldwide: 32,136,910 shares worth $1.83B.
- BlackRock added most to Amazon in Q2 2020, an estimated $2.16B increase.
- BlackRock's biggest Q2 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $1.67B.
- BlackRock fully exited Allergan plc in Q2 2020, selling an estimated $3.74B.
- BlackRock's ten largest holdings make up 19% of its $2.51T portfolio in Q2 2020.
- BlackRock opened 247 new positions and closed 215 in Q2 2020.
- BlackRock's portfolio value rose 23% quarter-over-quarter to $2.51T.
Based on BlackRock's 13F filing for Q2 2020, filed 14 Aug 2020.